These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25171282)

  • 1. Grading variability of urothelial carcinoma: experience from a single academic medical center.
    Lee EW; Deng FM; Melamed J; Mendrinos S; Das K; Hochman T; Taneja SS; Huang WC
    Can J Urol; 2014 Aug; 21(4):7374-8. PubMed ID: 25171282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
    Tuna B; Yörükoglu K; Düzcan E; Sen S; Nese N; Sarsık B; Akder A; Sayhan S; Mungan U; Kirkali Z
    Virchows Arch; 2011 Jun; 458(6):659-64. PubMed ID: 21484429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated Detection and Grading of Non-Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.
    Jansen I; Lucas M; Bosschieter J; de Boer OJ; Meijer SL; van Leeuwen TG; Marquering HA; Nieuwenhuijzen JA; de Bruin DM; Savci-Heijink CD
    Am J Pathol; 2020 Jul; 190(7):1483-1490. PubMed ID: 32283104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis.
    Colling R; Colling H; Browning L; Verrill C
    BMC Cancer; 2021 Sep; 21(1):995. PubMed ID: 34488682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders.
    Robertson AJ; Beck JS; Burnett RA; Howatson SR; Lee FD; Lessells AM; McLaren KM; Moss SM; Simpson JG; Smith GD
    J Clin Pathol; 1990 Jan; 43(1):17-21. PubMed ID: 2312745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
    Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T
    Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.
    Reid MD; Osunkoya AO; Siddiqui MT; Looney SW
    Int J Clin Exp Pathol; 2012; 5(9):882-91. PubMed ID: 23119105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma.
    Downes MR; Slodkowska E; Katabi N; Jungbluth AA; Xu B
    Histopathology; 2020 Jan; 76(2):191-200. PubMed ID: 31243779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of staging and grading of bladder tumours. Impact of misinformation on the pathologist's diagnosis.
    Olsen LH; Overgaard S; Frederiksen P; Ladefoged C; Ludwigsen E; Petri J; Poulsen JT
    Scand J Urol Nephrol; 1993; 27(3):349-53. PubMed ID: 8290915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.
    Mariappan P; Fineron P; O'Donnell M; Gailer RM; Watson DJ; Smith G; Grigor KM
    World J Urol; 2021 Feb; 39(2):425-431. PubMed ID: 32266509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
    Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
    BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
    Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
    Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
    Mamoon N; Iqbal MA; Jamal S; Luqman M
    J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.
    Yorukoglu K; Tuna B; Dikicioglu E; Duzcan E; Isisag A; Sen S; Mungan U; Kirkali Z
    Virchows Arch; 2003 Dec; 443(6):734-40. PubMed ID: 14534785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma.
    Chen YB; Tu JJ; Kao J; Zhou XK; Chen YT
    Arch Pathol Lab Med; 2008 Feb; 132(2):224-31. PubMed ID: 18251581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic analysis of nuclear features reveals a non-tumoral predictor of tumor grade in bladder cancer.
    Fahoum I; Tsuriel S; Rattner D; Greenberg A; Zubkov A; Naamneh R; Greenberg O; Zemser-Werner V; Gitstein G; Hagege R; Hershkovitz D
    Diagn Pathol; 2024 Jun; 19(1):75. PubMed ID: 38851736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.
    Kvikstad V; Mangrud OM; Gudlaugsson E; Dalen I; Espeland H; Baak JPA; Janssen EAM
    Diagn Pathol; 2019 Aug; 14(1):90. PubMed ID: 31412916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma.
    Slotman A; Xu M; Lindale K; Hardy C; Winkowski D; Baird R; Chen L; Lal P; van der Kwast T; Jackson CL; Gooding RJ; Berman DM
    Lab Invest; 2023 Jul; 103(7):100155. PubMed ID: 37059267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.